Medical 21, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-23.
Medical 21, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 23, 2026. The filing reports $550K sold. Its industry group is Biotechnology. It names Manny Villafana (Executive Officer, Director), Eric Solien (Executive Officer), Jeff Vreeman (Executive Officer) (SEC Form D, October 23, 2026).
Sell to companies like Medical 21, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Medical 21, Inc.
Free to see. No signup.
More on the people and the money behind Medical 21, Inc., from the filings we hold.
Biotechnology raises by companies based in Minnesota, filed within 90 days of this one, largest first.
Get an email when Medical 21, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Medical 21, Inc. raises, hires or launches. No email unless you switch it on.
Watch Medical 21, Inc. →Get the full cited report on Medical 21, Inc.
What the filing shows about Medical 21, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Medical 21, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Medical 21, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week. The dot is this raise, $550K, on the same scale — one filing against the whole group's total, so it sits low by construction.
A portion of the offering proceeds will be used for general working capital purposes, including the payment of salaries to officers.
Manny Villafana is named as Executive Officer and Director on the Form D that Medical 21, Inc. filed with the SEC on 23 October 2026, one of 4 people that filing names.
Eric Solien is named as Executive Officer on the Form D that Medical 21, Inc. filed with the SEC on 23 October 2026, one of 4 people that filing names.
Jeff Vreeman is named as Executive Officer on the Form D that Medical 21, Inc. filed with the SEC on 23 October 2026, one of 4 people that filing names.
Andrea Sweeney is named as Executive Officer on the Form D that Medical 21, Inc. filed with the SEC on 23 October 2026, one of 4 people that filing names.
4 people named on the filing — 4 holding an executive role.
Named as of the 2026-10-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Medical 21, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Medical 21, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medical 21, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Medical 21, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Medical 21, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Medical 21, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-10-19 · Biotech raises in Minneapolis-St. Paul
https://mentionfox.com/funding/medical-21-inc-form-d-033301